Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.medcli.2020.06.019 http://scihub22266oqcxt.onion/10.1016/j.medcli.2020.06.019 32718715!7346774!32718715     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32718715&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Med+Clin+(Barc) 2020 ; 155 (10): 448-453 Nephropedia Template TP {{tp|p=32718715|t=2020. Reacciones adversas a farmacos utilizados en el tratamiento especifico de la infeccion por SARS-CoV-2 |pdf=|usr=}}{{32718715}} gab.com Text Reacciones adversas a farmacos utilizados en el tratamiento especifico de la infeccion por SARS-CoV-2 JO: Med Clin (Barc) http://www.kidney.de/pget.php?&tw=1&pmid=32718715 #FOAvip Currently, there is no treatment approved for COVID-19. Numerous drugs are being used in an empirical manner according to experience and availability. Studies demonstrating their efficacy and safety are still to be published. Thus, it is of vital importance for healthcare workers to be well informed and updated regarding possible immunological and non-immunological adverse effects regarding such treatments. In this narrative revision, the rationale use of these treatments in the SARS-CoV-2 infection is emphasized as well as their most frequently described adverse drug reactions. Drugs that are being essayed to counteract both clinical phases that are thought to take place in the severe stage of this disease are included; an initial phase where a viral infection prevails and a second phase where an inflammatory response takes over. Adverse reactions registered in the Pharmacovigilance Program of our hospital before the onset of this pandemic have also been included. Twit Text FOAVip Reacciones adversas a farmacos utilizados en el tratamiento especifico de la infeccion por SARS-CoV-2 ????Med Clin (Barc) http://www.kidney.de/pget.php?&tw=1&pmid=32718715 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32718715 #FOAvip English Wikipedia <ref>{{Cite pmid|32718715}}</ref> Reacciones adversas a farmacos utilizados en el tratamiento especifico de la infeccion por SARS-CoV-2 #MMPMID32718715 Herrera-Lasso Regas V; Dordal Culla MT; Lleonart Bellfill R Med Clin (Barc) 2020[Nov]; 155 (10): 448-453 PMID32718715show ga Currently, there is no treatment approved for COVID-19. Numerous drugs are being used in an empirical manner according to experience and availability. Studies demonstrating their efficacy and safety are still to be published. Thus, it is of vital importance for healthcare workers to be well informed and updated regarding possible immunological and non-immunological adverse effects regarding such treatments. In this narrative revision, the rationale use of these treatments in the SARS-CoV-2 infection is emphasized as well as their most frequently described adverse drug reactions. Drugs that are being essayed to counteract both clinical phases that are thought to take place in the severe stage of this disease are included; an initial phase where a viral infection prevails and a second phase where an inflammatory response takes over. Adverse reactions registered in the Pharmacovigilance Program of our hospital before the onset of this pandemic have also been included. |*COVID-19 Drug Treatment[MESH] |Anti-Inflammatory Agents/*adverse effects/therapeutic use[MESH] |Antiviral Agents/*adverse effects/therapeutic use[MESH] |Humans[MESH] |Pharmacovigilance[MESH]Reacciones adversas a farmacos utilizados en el tratamiento especifico(epmc).pdf DeepDyve Pubget Overpricing